Energy Energy

Google's DeepMind's Covid-19 protein research shows cost of not using AI in emergencies

By Matthew Newman
  • 25 Mar 2020 11:43
  • 25 Mar 2020 11:43
Google’s DeepMind unit’s use of artificial intelligence to help speed up the discovery of a Covid-19 vaccine shows that there may be a cost for not using AI in urgent situations, a Google official said today.
“The crisis is exposing that there might be some risks in not using AI

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Matthew Newman

Chief Correspondent


Matthew Newman is a chief correspondent for MLex and writes about data protection, privacy, telecoms, cyber security and artificial intelligence. Matthew began his journalism career in 1991 in community newspapers. He worked as a reporter in Riga, Latvia in 1993 and then moved to Chicago where he covered local news. In 1995, he became a personal finance reporter for Dow Jones Newswires, and was then transferred to Brussels in 1999. He specialized in EU regulatory affairs, including trade and telecom issues. He began covering competition for Bloomberg News as an EU court reporter in 2004. In 2010, he was named spokesman for Viviane Reding, the EU’s justice commissioner. In January 2012, he helped launch the commission’s proposal to overall data protection rules.

Discover MLex

Stay on top of global regulatory developments

Latest News